Thursday, December 8, 2021
4:00pm PT | 7:00pm ET | 8:00pm AT
International expert Bertrand Tombal
Canadian KOL: Fred Saad
1. role of bone targeted therapies in the overall management of advanced prostate cancer
2. timing and available options in bone targeted therapies
3. advantages and risks when combining bone targeted agents with available life prolonging therapies for advanced prostate cancer
SERIES SPONSOR: Amgen, Janssen
Accredited for Section 1 Credits √
Questions? Contact Tal at the CUA - firstname.lastname@example.org
NOTE: For CUA members who would like this activity recorded in their profile, please use the email that is associated with your CUA membership.
Medical oncologists – for complimentary CUA membership, please visit www.cua.org/become-a-member and select Associate Member.
***This webinar is reserved for healthcare professionals and sponsoring companies. However, CUA reserves the right to cancel registration if deemed necessary.***
Un service d’interprétation simultanée en français sera offert pendant le webinaire.